Laddar...
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
BACKGROUND: Nivolumab is an anti-PD1 checkpoint inhibitor active in patients with advanced melanoma and as adjuvant therapy in high-risk metastatic melanoma patients. METHODS: In this single-center retrospective analysis, we investigated the CD73 enzyme activity in patients with metastatic melanoma...
Sparad:
| I publikationen: | J Transl Med |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5716054/ https://ncbi.nlm.nih.gov/pubmed/29202855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-017-1348-8 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|